In this episode of Better Thinking, Nesh Nikolic speaks with Dr. David Healy about how psychotropic drugs and clinical trials have influenced the way we understand mental health and the broader impact these developments have had on society.
David Healy, a professor in the Department of Family Medicine in McMaster University, Hamilton, Ontario, is a doctor, psychiatrist, psychopharmacologist, scientist and author. His main areas of research are the contribution of antidepressants to suicide, conflict of interest between pharmaceutical companies and academic medicine, and the history of pharmacology. Healy has written more than 200 peer-reviewed articles, 200 other articles, and 24 books, including The Antidepressant Era, The Creation of Psychopharmacology, The Psychopharmacologists Volumes 1–3, Let Them Eat Prozac, and Mania: A Short History of Bipolar Disorder.
He has been involved as an expert witness in homicide and suicide trials involving psychotropic drugs. He has brought concerns about some medications to the attention of drug regulators. He has also said that pharmaceutical companies sell drugs by marketing diseases and co-opting academic opinion-leaders. In his 2012 book Pharmageddon, he argues that pharmaceutical companies have dominated healthcare in America, often with life-threatening results for patients. Healy is a founder and chief executive officer of Data Based Medicine Limited, which aims to make medicines safer through RxISK – Prescription Drug Side Effects an “online direct patient reporting of drug effects” platform.
